20-Year prevalence projections for dementia and impact of preventive policy about risk factors (Q39404129)

11 September 2017

title

20-Year prevalence projections for dementia and impact of preventive policy about risk factors (English)

1 reference

11 September 2017

0 references

Hélène Jacqmin-Gadda

1 reference

11 September 2017

Christophe Tzourio

0 references

Daniel Commenges

1 reference

11 September 2017

Jean-François Dartigues

object named as

Jean-François Dartigues

1 reference

11 September 2017

Carole Dufouil

1 reference

11 September 2017

Claire Montlahuc

1 reference

11 September 2017

Annick Alperovitch

1 reference

11 September 2017

Karen Leffondre

1 reference

11 September 2017

Alexis Elbaz

1 reference

11 September 2017

Joël Ménard

1 reference

11 September 2017

Pierre Joly

1 reference

11 September 2017

language of work or name

1 reference

12 June 2013

1 reference

European Journal of Epidemiology

11 September 2017

published in

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

493-502

1 reference

2012 Alzheimer's disease facts and figures

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

The projected effect of risk factor reduction on Alzheimer's disease prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Methods for projecting the incidence and prevalence of chronic diseases in aging populations: application to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Forecasting the global burden of Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

A penalized likelihood approach for an illness-death model with interval-censored data: application to age-specific incidence of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Mortality in elderly Canadians with and without dementia: a 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Hypertension, cognitive decline and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

APOE and Alzheimer disease: a major gene with semi-dominant inheritance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Predictors of cognitive decline and mortality of aged people over a 10-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Medicine. Old drug, new hope for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Prevalence projections of chronic diseases and impact of public health intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Incidence and mortality of Alzheimer's disease or dementia using an illness-death model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

On the Nature of the Function Expressive of the Law of Human Mortality, and on a New Mode of Determining the Value of Life Contingencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

Prodromal Alzheimer's disease: successive emergence of the clinical symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9818-7

[Prevalence of dementia and Alzheimer's disease among subjects aged 75 years or over: updated results of the PAQUID cohort].

21 January 2018

1 reference

12 December 2020

A review of the major vascular risk factors related to Alzheimer's disease

1 reference

12 December 2020

Deciphering death: a commentary on Gompertz (1825) 'On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies'.

1 reference

12 December 2020

Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

1 reference

12 December 2020

Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studies

1 reference

12 December 2020

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

12 December 2020

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

12 December 2020

Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

1 reference

12 December 2020

10.1007/S10654-013-9818-7

Identifiers

DOI

1 reference

11 September 2017

1 reference